Recorded fact · drug.trial_access

drug.trial_access for tofacitinib

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact b66b27e0 resolves to.

The record

Fact id	`b66b27e0e9f6100f557c4044`
Entity	drug: tofacitinib
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "TOFACITINIB",
 "recruitingInterventionalCount": 28,
 "notYetRecruitingCount": 11,
 "byPhase": {
  "PHASE2": 7,
  "PHASE3": 4,
  "PHASE1": 1,
  "PHASE4": 10,
  "NA": 5,
  "EARLY_PHASE1": 1
 },
 "trials": [
  {
   "nctId": "NCT07281456",
   "briefTitle": "Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "National Institute of Dental and Craniofacial Research (NIDCR)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-02",
   "startDate": "2025-12-18",
   "conditions": [
    "Sjogren's Syndrome"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07281456"
  },
  {
   "nctId": "NCT06654882",
   "briefTitle": "Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Duke University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-21",
   "startDate": "2026-01-09",
   "conditions": [
    "Polyarticular Course Juvenile Idiopathic Arthritis (JIA)"
   ],
   "countries": [
    "United States",
    "Germany",
    "Italy",
    "Netherlands"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06654882"
  },
  {
   "nctId": "NCT07843693",
   "briefTitle": "A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "AbbVie",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-28",
   "startDate": "2026-08-26",
   "conditions": [
    "Healthy Volunteers"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07843693"
  },
  {
   "nctId": "NCT04692493",
   "briefTitle": "RA-PRO PRAGMATIC TRIAL",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "University of Alabama at Birmingham",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-24",
   "startDate": "2021-09-22",
   "conditions": [
    "Rheumatoid Arthritis"
   ],
   "countries": [
    "United States",
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04692493"
  },
  {
   "nctId": "NCT07598643",
   "briefTitle": "Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "University of Colorado, Denver",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-03",
   "startDate": "2026-05-28",
   "conditions": [
    "Down Syndrome"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07598643"
  },
  {
   "nctId": "NCT07406035",
   "briefTitle": "A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-02",
   "startDate": "2026-07-16",
   "conditions": [
    "Psoriatic Arthritis"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07406035"
  },
  {
   "nctId": "NCT06687551",
   "briefTitle": "JAK Inhibitor Dose TAPering Strategy Study",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "University Hospital, Toulouse",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-08-07",
   "startDate": "2025-06-06",
   "conditions": [
    "Rheumatoid Arthritis (RA"
   ],
   "countries": [
    "France"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06687551"
  },
  {
   "nctId": "NCT07721142",
   "briefTitle": "Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-07-22",
   "startDate": "2025-10-15",
   "conditions": [
    "Rheumatoid Arthritis (RA)"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07721142"
  },
  {
   "nctId": "NCT06698822",
   "briefTitle": "A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "M.D. Anderson Cancer Center",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-07-13",
   "startDate": "2025-03-10",
   "conditions": [
    "Cutaneous T-Cell Lymphoma"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06698822"
  },
  {
   "nctId": "NCT07138898",
   "briefTitle": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "NYU Langone Health",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-07-09",
   "startDate": "2025-12-12",
   "conditions": [
    "Rheumatic Disease"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07138898"
  },
  {
   "nctId": "NCT03414502",
   "briefTitle": "Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "University of Nebraska",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-06-17",
   "startDate": "2007-12-10",
   "conditions": [
    "Rheumatoid Arthritis"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT03414502"
  },
  {
   "nctId": "NCT07406932",
   "briefTitle": "A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome",
   "phase": [
    "NA"
   ],
   "leadSponsor": "China-Japan Fr
... (shortened here; the full value is in the JSON twin)

SHA-256 of the exact stored value: cac05f5217576fa3328e0cd274ad8f203e800c448fd1c2f811834e8b1ce4af1b.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.